Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

Samuel Blake, also known professionally as Sam Blake or Samuel Stewart Blake, is pioneering two rapidly growing ventures that ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

But within weeks, Novo Nordisk’s partnership crumbled amid a messy war of words. Novo Nordisk accused Hims & Hers of continuing to deceptively sell large volumes of copycat vers ...

GLP-1 medications like semaglutide and tirzepatide are helping people shed weight and keep it off. But let’s be clear: These aren’t miracle pills you buy off ...

Biotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.

Luka Doncic, the future face of the Los Angeles Lakers, recently gained significant attention due to his impressive offseason ...

Researchers conducted the SOUL clinical trial to assess the effect of oral semaglutide on cardiovascular outcomes across different HbA1c and BMI statuses in type 2 diabetes.

WEIGHT loss jabs could raise the risk of sudden blindness, a study warns. Injections like Wegovy, Mounjaro and Ozempic are ...

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...

Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...